Article Details

Shares in genetic testing company 23andMe surge on SPAC merger debut

Retrieved on: 2021-06-18 03:00:00

Tags for this article:

Click the tags to see associated articles and topics

Shares in genetic testing company 23andMe surge on SPAC merger debut. View article details on hiswai:

Excerpt

Coming into its SPAC listing, 23andMe had raised $868.6 million, according to Crunchbase, including $82.5 million from Sequoia Capital and ...

Article found on: siliconangle.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up